QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.46%)
BABA   86.74 (+1.40%)
AMD   102.82 (+0.06%)
T   15.02 (+0.07%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.79%)
GE   110.55 (-1.59%)
DIS   81.05 (+1.15%)
AMC   7.99 (+2.57%)
PFE   33.17 (+3.37%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.46%)
BABA   86.74 (+1.40%)
AMD   102.82 (+0.06%)
T   15.02 (+0.07%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.79%)
GE   110.55 (-1.59%)
DIS   81.05 (+1.15%)
AMC   7.99 (+2.57%)
PFE   33.17 (+3.37%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.46%)
BABA   86.74 (+1.40%)
AMD   102.82 (+0.06%)
T   15.02 (+0.07%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.79%)
GE   110.55 (-1.59%)
DIS   81.05 (+1.15%)
AMC   7.99 (+2.57%)
PFE   33.17 (+3.37%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.46%)
BABA   86.74 (+1.40%)
AMD   102.82 (+0.06%)
T   15.02 (+0.07%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.79%)
GE   110.55 (-1.59%)
DIS   81.05 (+1.15%)
AMC   7.99 (+2.57%)
PFE   33.17 (+3.37%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
NASDAQ:HSCS

Heart Test Laboratories (HSCS) Stock Forecast, Price & News

$0.44
+0.02 (+4.17%)
(As of 04:20 PM ET)
Compare
Today's Range
$0.41
$0.46
50-Day Range
$0.38
$0.97
52-Week Range
$0.30
$3.95
Volume
38,130 shs
Average Volume
940,053 shs
Market Capitalization
$4.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.15

Heart Test Laboratories MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
615.9% Upside
$3.15 Price Target
Short Interest
Healthy
0.54% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.59mentions of Heart Test Laboratories in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.16 out of 5 stars


HSCS stock logo

About Heart Test Laboratories (NASDAQ:HSCS) Stock

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

HSCS Price History

HSCS Stock News Headlines

This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
See More Headlines
Receive HSCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Heart Test Laboratories and its competitors with MarketBeat's FREE daily newsletter.

HSCS Company Calendar

Last Earnings
7/19/2023
Today
9/29/2023
Next Earnings (Estimated)
12/21/2023
Fiscal Year End
4/30/2024

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:HSCS
Fax
N/A
Employees
12
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$3.15
High Stock Price Forecast
$3.30
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+645.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-6,350,000.00
Pretax Margin
-307,400.00%

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.05) per share

Miscellaneous

Free Float
9,327,000
Market Cap
$4.61 million
Optionable
Not Optionable
Beta
4.01
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Andrew Simpson (Age 54)
    CEO, Pres & Chairman of Directors
    Comp: $264.14k
  • Ms. Danielle Watson (Age 41)
    CFO & Treasurer
    Comp: $188.75k
  • Mr. Mark T. Hilz (Age 64)
    COO, Sec. & Director
    Comp: $263.61k













HSCS Stock - Frequently Asked Questions

Should I buy or sell Heart Test Laboratories stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Heart Test Laboratories in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" HSCS shares.
View HSCS analyst ratings
or view top-rated stocks.

What is Heart Test Laboratories' stock price forecast for 2023?

2 equities research analysts have issued 1 year target prices for Heart Test Laboratories' stock. Their HSCS share price forecasts range from $3.00 to $3.30. On average, they predict the company's share price to reach $3.15 in the next twelve months. This suggests a possible upside of 645.7% from the stock's current price.
View analysts price targets for HSCS
or view top-rated stocks among Wall Street analysts.

How have HSCS shares performed in 2023?

Heart Test Laboratories' stock was trading at $0.8399 at the start of the year. Since then, HSCS shares have decreased by 49.7% and is now trading at $0.4224.
View the best growth stocks for 2023 here
.

Are investors shorting Heart Test Laboratories?

Heart Test Laboratories saw a decline in short interest in the month of September. As of September 15th, there was short interest totaling 37,000 shares, a decline of 10.4% from the August 31st total of 41,300 shares. Based on an average daily trading volume, of 94,900 shares, the days-to-cover ratio is currently 0.4 days. Approximately 0.5% of the shares of the company are short sold.
View Heart Test Laboratories' Short Interest
.

When is Heart Test Laboratories' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, December 21st 2023.
View our HSCS earnings forecast
.

How were Heart Test Laboratories' earnings last quarter?

Heart Test Laboratories, Inc. (NASDAQ:HSCS) issued its earnings results on Wednesday, July, 19th. The company reported ($0.16) earnings per share for the quarter.

When did Heart Test Laboratories IPO?

(HSCS) raised $9 million in an IPO on Wednesday, June 15th 2022. The company issued 1,800,000 shares at a price of $4.50-$5.50 per share. The Benchmark Company served as the underwriter for the IPO.

What is Heart Test Laboratories' stock symbol?

Heart Test Laboratories trades on the NASDAQ under the ticker symbol "HSCS."

How do I buy shares of Heart Test Laboratories?

Shares of HSCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Heart Test Laboratories' stock price today?

One share of HSCS stock can currently be purchased for approximately $0.42.

How much money does Heart Test Laboratories make?

Heart Test Laboratories (NASDAQ:HSCS) has a market capitalization of $4.61 million. The company earns $-6,350,000.00 in net income (profit) each year or ($0.67) on an earnings per share basis.

How can I contact Heart Test Laboratories?

The official website for the company is heartsciences.com. The company can be reached via phone at 682-237-7781 or via email at hscs@crescendo-ir.com.

This page (NASDAQ:HSCS) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -